20152018

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Jessica-Anne Weir is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 3 Conference contribution
  • 2 Article
  • 1 Meeting abstract

Targeting the dopamine receptor 2 in BRAF mutant colorectal cancer

Javadi, A., Forsythe, N., Refaat, A., Weir, J-A., Khawaja, H., Waugh, D., Tarapore, R., Allen, J. E., Johnston, P. & Van Schaeybroeck, S., Jul 2018, In : Cancer Research. 78, Issue 13 Supplement, 1 p., Abstract 3448.

Research output: Contribution to journalMeeting abstract

The unfolded protein response: a novel therapeutic target for poor prognostic BRAF mutant colorectal cancer

Forsythe, N., Refaat, A., Javadi, A., Khawaja, H., Weir, J-A., Emam, H., Allen, W. L., Burkamp, F., Popovici, V., Jithesh, P. V., Isella, C., Labonte, M. J., Mills, I. G., Johnston, P. G. & Van Schaeybroeck, S., 26 Feb 2018, In : Molecular Cancer Therapeutics.

Research output: Contribution to journalArticle

Open Access
File
  • 4 Citations (Scopus)
    300 Downloads (Pure)

    The unfolded protein response: a novel therapeutic target for poor prognostic BRAF mutant colorectal cancer

    Van Schaeybroeck, S., Forsythe, N., Refaat, A., Javadi, A., Khawaja, H., Weir, J-A., Emam, H., Moore, W., Burkamp, F., Popovici, V., Jithesh, P., Isella, C., LaBonte Wilson, M., Mills, I. & Johnston, P., 2017, The unfolded protein response: a novel therapeutic target for poor prognostic BRAF mutant colorectal cancer. National Cancer Research Insitute

    Research output: Chapter in Book/Report/Conference proceedingConference contribution

  • ADAM17: a potential regulator of resistance to EGFR targeted therapies in RAS wild type colorectal cancer.

    Weir, J-A., Gilliland, P., Fuchs, M-A., Williams, R., Murray, L., Johnston, P. & Van Schaeybroeck, S., Nov 2016, ADAM17: a potential regulator of resistance to EGFR targeted therapies in RAS wild type colorectal cancer.. National Cancer Research Institute

    Research output: Chapter in Book/Report/Conference proceedingConference contribution

  • EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal Cancer

    Dunne, P. D., Dasgupta, S., Blayney, J. K., McArt, D. G., Redmond, K. L., Weir, J-A., Bradley, C. A., Sasazuki, T., Shirasawa, S., Wang, T., Srivastava, S., Ong, C. W., Arthur, K., Salto-Tellez, M., Wilson, R. H., Johnston, P. G. & Van Schaeybroeck, S., 01 Jan 2016, In : Clinical Cancer Research. 22, 1, p. 230-242 13 p.

    Research output: Contribution to journalArticle

  • 55 Citations (Scopus)